Hachshara Hitachdashut 2025: Execution Has Started, but the Shareholder Test Still Runs Through Cash and Partners

Company Overview

Hachshara Hitachdashut is not a standard residential developer. It is a nearly pure urban-renewal platform, with no classic land-bank model, more than 32,000 potential units across its portfolio, and more than 9,500 units in advanced projects. That matters because the most tempting number here is not the current year's profit but the size of the pipeline. That is also the trap. The 2025 report should not be read as a question of how many units exist on paper. It should be read as a question of how much of that pipeline actually moved this year from a planning story into an execution story, and at what cost to common shareholders.

What is clearly working now is the shift into execution. As of the investor presentation, the company shows 1,183 units in projects already under construction or marketing, with expected gross profit of NIS 253 million attributable to the company, of which NIS 244 million had not yet been recognized. In parallel, another 1,126 units are presented as projects expected to be ready for construction in 2026, with another NIS 233 million of company-share expected gross profit. The presentation also shows 141 units sold or marketed from the start of 2025 through the presentation date, for about NIS 355 million including VAT. In other words, this is no longer just a slide deck without active sites.

But this is exactly where a superficial read goes wrong. The consolidated 2025 report is still small relative to the operating story management is telling. Revenue rose to NIS 62.8 million, but gross profit was only NIS 5.3 million, operating loss was NIS 12.4 million, and the group still ended the year with a comprehensive loss of NIS 1.4 million. At the same time, cash and cash equivalents fell by NIS 40.2 million, inventory for sale jumped to NIS 196.6 million, and the company still needed a private placement of about NIS 30 million in February 2026. Execution has started, but the accounts still do not look like those of a business already harvesting that execution.

The main reason is that value is now being created in several layers that do not flow into common-shareholder earnings at the same pace. Part of the projects sit in structures with Menora, so part of the capital already appears as minority interest. Hankin, which has already entered execution, is accounted for as an associate rather than a consolidated project, so it does not yet feed the top line the way a consolidated project would. And the company itself says that most current sales are being made on 20/80 terms that are not fully indexed to the construction-input index. So the active bottleneck for 2026 is no longer just getting more plans approved. The real bottleneck is turning the execution ramp into profitability and cash without giving too much of the economics away to partners, financiers, and soft sales terms.

The Economic Map Right Now

Those two charts are the core of the read. On one hand, the economic reservoir is already much bigger than what the income statement shows. On the other hand, common shareholders still cannot treat that reservoir as if it were already cash, or even already net profit. It is still operating promise that has to pass through financing, partners, sales quality, and accounting timing.

Events and Triggers

The key insight is that 2025 and early 2026 changed what kind of company this is. Until recently, Hachshara Hitachdashut was mainly a story of signatures, plans, and permits. Now it is already a company with active construction sites, equity partners, project-finance facilities, and contractor agreements. That is a real improvement. But it also shifts the center of gravity from planning risk to capital-structure risk.

Menora solved part of the bottleneck, but also took part of the upside

During 2025 the cumulative conditions under Menora 1 were met, and Menora injected about NIS 53 million into the Hankin and Ben Gurion stage A partnerships. That capital appears at year-end as NIS 51.3 million of non-controlling interests. This is critical. Anyone looking only at total equity, NIS 188 million, could conclude that the company built a wide equity cushion. But more than a quarter of that equity already belongs to partners.

In November 2025 Menora 2 was also signed. The structure is straightforward: up to NIS 250 million of aggregate equity across six projects, of which up to NIS 200 million comes from Menora and up to NIS 50 million from Hayishuv Hehadash. Under the agreement, Menora funds 80% of the required equity in each project and the company funds 20%. The waterfall reflects an indicative profit split of roughly 60% to the company group and 40% to Menora, but the filing stresses that the actual split may end up materially different. In other words, Menora genuinely eases the equity bottleneck, but it does not do so for free. It buys a meaningful share of the upside.

Three sites moved into execution in just over a month

On December 8, 2025 construction began at Hankin in Holon, a 130-unit project with 94 units for sale. On January 2, 2026 construction began at Bavli Yerushalmi in Tel Aviv, a 56-unit project with 34 units for sale. On January 13, 2026 construction began at stage A of Ben Gurion in Ramla, a 270-unit project with 222 units for sale. The presentation frames those three moves as more than 450 units that entered execution within about a month. That is the real positive trigger of the year.

But even here it is important to separate site activity from what common shareholders actually see in the accounts. Hankin is the clearest example. The project entered execution in December 2025, but it sits in an associate rather than a consolidated subsidiary, so in 2025 it shows up mainly as a NIS 41.6 million investment and as part of the company's share of associate losses. The cranes went up. The revenue line did not.

2026 is getting closer, but not cleaner

In December 2025 the committee approved a full building permit in conditions for the HaAliya HaShniya project in Haifa. The project includes 715 residential units and 16 retail units, of which 539 residential units and 6 retail units are for sale by the developers, and the company holds 50%. Management estimates that the full permit itself should be obtained in the third quarter of 2026, with construction beginning only after that. So this is a project that materially advances the 2026 story, but it is still not an execution project today.

In January 2026 the district committee also granted final approval after objections for the Borochov project in Jerusalem. The project is planned for 190 new units instead of 46 existing units, signature coverage stands at about 75%, and the company estimates that the main conditions for construction will be met in 2027. This is a meaningful planning win, but not one that justifies jumping to the conclusion that 2026 has already been de-risked.

After the balance-sheet date, the company is still buying time

Two post-balance-sheet events make it clear that financing remains central. In February 2026 the company raised about NIS 30 million gross in a private placement, in exchange for 2,995,587 shares and the same number of non-traded warrants. In March 2026 the parent company, Hachsharat Hayishuv, also extended the guarantee framework it provides for the company's obligations and those of its controlled subsidiaries. Both moves are positive because they buy time. They also remind investors that this time is still being purchased.

Efficiency, Profitability, and Competition

The central story of 2025 is a sharp gap between what is happening on the ground and what currently appears in the consolidated income statement. That is not a contradiction, but it is the key to understanding the stock. Anyone looking only at the consolidated report will see limited improvement. Anyone looking only at the pipeline will see a huge growth engine. The truth sits in the middle: the company has moved into a new phase, but common-shareholder economics are still lagging the operating ramp.

A big pipeline report, a small revenue report

2025 revenue reached NIS 62.8 million, versus NIS 38.5 million in 2024. Of that, NIS 45.1 million came from apartment sales and NIS 17.7 million from construction services. But the filing itself explains that 2025 revenue was mainly attributable to Lisin in Tel Aviv, which was completed during the year, and De Haaz in Tel Aviv, where construction had already started back in 2023. The inventory notes make the same point: Lisin was completed and received its completion certificate in September 2025, while De Haaz ended the year with only NIS 8.9 million of inventory remaining after all units for sale had been sold.

In other words, what was recognized in 2025 still came mainly from relatively older projects. The three sites that moved into execution between December 2025 and January 2026 had not yet had time to become meaningful reported revenue. That is why the company still looks like it is in-between stages: execution is already here, but the accounts still reflect the past more than the future.

Profitability is still too thin

Gross profit rose to NIS 5.3 million, but that is still only about an 8.4% gross margin. After NIS 2.2 million of preliminary development expense, NIS 12.0 million of G&A, NIS 3.4 million of selling expense, and NIS 0.6 million of share in associate losses, the company remained at an operating loss of NIS 12.4 million. The reason the bottom line ended up only slightly negative is basically twofold: financing expense dropped sharply versus 2024, and the company recorded a NIS 12.6 million tax benefit.

That is exactly where investors should be careful not to confuse improvement with normalization. 2025 was not the year in which the company proved a clean profitable model. It was the year in which structural improvement started, but was still supported by tax, accounting timing, and a recognition profile that still does not match the full scale of the operating build-out.

That chart matters because it breaks the illusion of a smooth inflection year. Revenue stepped down through the year to just NIS 9 million in the fourth quarter, and the group was effectively back at breakeven. The report itself says the main difference between Q4 and the rest of the year was that the tax benefit was recognized only in Q2 and Q3. So even in the year when the operating narrative improved, the bottom line still did not become a stable anchor.

Revenue is concentrated too

In the revenue note the company discloses that NIS 28.5 million of 2025 revenue came from one major customer. That is about 45% of the year's total revenue. The company does not disclose the identity of that customer, so the exact commercial exposure cannot be mapped. But the size of the concentration is enough to show that 2025 revenue still rests on a relatively narrow base. This is not yet a company with naturally diversified earnings streams flowing from many stabilized active sites.

Sales quality matters as much as sales volume

The presentation gives a reasonably strong marketing picture: 141 units were sold or marketed from the start of 2025 through the presentation date, including 71 units in Kiryat Yam and 48 in Ben Gurion Ramla. But the risk section adds what the presentation does not emphasize: most current sales are being made on 20/80 terms that are not fully indexed to the construction-input index.

The industry discussion in the filing adds another layer. It explains that, in the current market, structures like these imply an economic discount of roughly 5.3% to 7% from list price, raise developer liquidity risk, and increase the risk that buyers will struggle to finance the deferred balance later. That is not a footnote. It means that even if sales pace is being preserved, the quality of that growth may be weaker than the headline suggests.

That distribution sharpens two points. First, 2025 marketing was carried mainly by two projects, Kiryat Yam and Ramla, rather than by broad-based diversification across the whole pipeline. Second, projects that have not yet fully entered construction can still carry the marketing headline. So in the next report the real question will be less how many units were marketed and more on what terms, with what collection pace, and with what conversion into accounting revenue and cash.

Cash Flow, Debt, and Capital Structure

When the main thesis is execution versus financing, the right frame is all-in cash flexibility. It is not enough to ask how much expected gross profit sits in the projects. The real question is how much cash remains after the year's actual uses, and what really belongs to the common shareholder layer.

What actually happened to cash

In 2025 the group burned NIS 67.6 million in operating activity. That is the single most important number in the whole report. This is not merely a business that has not yet started harvesting the pipeline. It is a business that is still consuming cash to move inventory, planning, construction services, and advance-rent commitments to existing rights holders.

Investing activity showed a positive NIS 3.3 million, but that did not reflect a lack of investment. It mainly reflected a net NIS 7.0 million release of restricted cash, offset by a NIS 3.6 million investment in the Hankin associate. Financing activity added NIS 24.2 million, driven mainly by NIS 53.0 million of non-controlling-interest inflows and NIS 5.3 million from warrant exercises, but reduced by NIS 30.4 million of repayment to the parent, NIS 5.5 million lower short-term bank credit, and NIS 0.45 million of lease payments.

The bottom line is straightforward: cash and cash equivalents fell from NIS 73.0 million to NIS 32.7 million. If restricted cash is included, the broader cash picture fell from NIS 116.4 million to NIS 69.2 million. That is a decline of roughly NIS 47.3 million in a year when Menora came in with real capital and warrant holders added equity.

Equity looks stronger than what common shareholders actually have

The presentation prefers to show total equity of NIS 188 million. The number is true, but incomplete. The statement of financial position makes clear that NIS 51.3 million of that total belongs to non-controlling interests. Equity attributable to the company's shareholders is only NIS 136.6 million. That is a very different picture.

The gap matters even more because the company is simultaneously showing company-share expected gross profit of NIS 253 million in projects already under construction or marketing and another NIS 233 million in projects maturing in 2026. Those are very large numbers relative to attributable equity. But that is exactly why investors should not blur the lines: this is expected gross profit, not net profit; some of the projects sit with partners; and part of the capital already brought in does not belong to common shareholders.

That chart tells the 2025 story without much interpretation. Inventory surged. Current liabilities surged. Attributable equity barely moved. What materially strengthened total equity largely accrued to the minority layer. In other words, shareholders got more operating scale, but not the same proportional increase in clean equity cushion.

Where the real debt burden sits

At the level of the consolidated balance sheet, direct financial debt looks manageable. At year-end there is only NIS 7 million of short-term bank debt, bullet due in August 2026, at prime plus 0.9%, and the parent loan is gone. Anyone stopping there could conclude that the capital structure has calmed down. That would be the wrong conclusion.

The real burden sits at the project layer. Hankin has facilities and guarantees totaling NIS 325 million, including NIS 50 million of cash credit. Bavli has NIS 440 million of total facilities, including NIS 63 million of cash credit. Ramla has NIS 500 million of facilities, including NIS 120 million of cash credit. De Haaz also has a facility framework of up to NIS 250 million. On top of that, in several of those packages the parent and the company itself are required to stand behind guarantees. So the pressure has moved from simple corporate debt to a structure of guarantees, collateral, closing conditions, and ongoing compliance with project-finance agreements.

HaAliya HaShniya is both opportunity and warning sign

The HaAliya HaShniya project in Haifa is a good example of the gap between value created and value accessible. On one hand, it is a 715-unit project with 539 units for sale, 96% signature coverage, and expected gross profit of NIS 135 million attributable to the company in the presentation. On the other hand, the financial statements show that the 2023 agreement with Bayit Vegag rests on a NIS 30 million loan to the company that was interest-free for 24 months but bears prime plus 1% if a building permit is not obtained in time. In addition, the company still has not recognized income from the inventory transfer, and the amounts received from Bayit Vegag remain booked as a liability while a 9.75% financing component is recognized.

In simple terms, this is a project that looks excellent at the expected gross-profit level, but is still consuming time, conditions precedent, and financing before it becomes accessible value. Even after the December 2025 committee decision, the full permit itself is still only expected in the third quarter of 2026. That is the clearest example of the difference between a quality pipeline and cash that is already in the common shareholder's pocket.

Outlook and Forward View

Before looking at 2026 and 2027, four findings need to be locked in because they are easy to miss on first read:

• Finding one: 2025 was the year of transition from planning execution to physical execution, but reported revenue and profit still came mainly from older projects rather than from the three sites that entered construction around year-end.
• Finding two: The Menora deals solved a large part of the equity bottleneck, but also turned a growing share of the future return into shared economics rather than full common-shareholder economics.
• Finding three: The company already shows an expected gross-profit reservoir of NIS 486 million attributable to the company across current execution/marketing projects and 2026-ready projects, but that is still gross profit before overhead, financing, minorities, and timing.
• Finding four: In the current market, the key question is not just whether the company can market units, but on what terms it sells them, how much cash it collects along the way, and what that does to financing flexibility for the next wave of projects.

2026 is a bridge year, 2027 is supposed to be the proof year

The presentation sets a clear bar: more than 500 units under construction today, roughly 1,000 units under construction in 2026, and more than 2,000 in 2027. That is an aggressive narrative, but it is not detached from the evidence. Kiryat Yam stages A+B is indeed presented as a project expected to enter execution by the end of 2026. HaAliya HaShniya is supposed to obtain the full permit and start afterwards. Ramla, Bavli, and Hankin have already started.

What is now being tested is no longer whether the projects exist. The test is whether 2026 can show two things at the same time:

• that the number of active construction sites genuinely rises without ripping open the cash profile again;
• and that the 2025 to early-2026 operating progress starts taking the form of recognized revenue, gross profit, and real advances, rather than just more inventory and more execution liabilities.

What has to happen over the next 2 to 4 quarters

Checkpoint one: Kiryat Yam stages A+B needs to move into actual execution during 2026. This is a 478-unit project with 399 units for sale and NIS 89 million of company-share expected gross profit. If that move happens, the market gets proof that the company can turn partner-backed planning into funded site activity.

Checkpoint two: HaAliya HaShniya needs to move from permit-in-conditions to a full permit and bank financing. This is the single largest 2026 pipeline project, so delay here matters more than almost any other individual project in the portfolio.

Checkpoint three: The February 2026 equity raise needs to look like time bought, not the opening of another capital-raising cycle. If after the three project starts and the Menora money the company still burns cash at the 2025 rate, the thesis weakens quickly.

Checkpoint four: The company needs to start producing more realized gross profit and less presentation-only gross profit. That does not mean the full NIS 486 million reservoir has to show up soon. It does mean that the figure has to start moving toward the financial statements rather than remain trapped in the presentation layer.

What kind of year is this, really

The right name for 2026 is a bridge year with a quality test. It is not a breakout year, because the capital structure and accounting conversion are not yet clean enough for that. It is also no longer just another year of planning dreams, because the sites are already moving. If 2026 delivers progress at Kiryat Yam, a full permit and financing at HaAliya HaShniya, and lower cash burn than in 2025, then 2027 can start to look like a genuine proof year. If not, the company will remain stuck in the uncomfortable middle ground where the potential is obvious but the accessible value is much less so.

Risks

The first risk is that the move into execution will burden the company faster than it can translate into revenue. That is already what happened in 2025: inventory surged, cash fell, and attributable equity barely grew. If 2026 looks similar, the market may stop worrying about the absence of projects and start worrying about having too many projects relative to the balance sheet.

The second risk is sales quality. The company itself says most current sales are being made on 20/80 terms that are not fully indexed to the construction-input index. At the sector level, the report describes those structures as implying a 5.3% to 7% economic discount and materially higher developer liquidity risk. That does not mean every company sale is problematic. It does mean that the unit count cannot be read without asking who is funding the gap until delivery.

The third risk is classic financing and execution risk. The company ranks the security situation, the domestic economy, the construction-input index, labor availability, and planning and licensing processes as high-impact risk factors. It ranks financing difficulty and financial leverage as medium-impact factors, but the filing itself shows that financing still sits at the center: without partners, guarantees, equity injections, and a private placement, 2025 would have looked far less comfortable.

The fourth risk is legal, even if not existential. There is a NIS 7.6 million claim linked to planning services at the Ben Gurion compound in Ramla, another NIS 2.5 million claim tied to the same services, a NIS 526 thousand claim tied to another project, and another NIS 374 thousand of ordinary-course claims. The company believes the two larger claims are more likely than not to be dismissed, while the third is still too early to assess. Those are not balance-sheet-threatening numbers on their own, but they do remind investors that the move from paper planning to real execution brings legal operating burden with it.

The fifth risk is liquidity and market read-through. Short interest in the stock rose to 0.59% of float on March 27, 2026, and SIR reached 11.84, the highest in its sector in the market-data file. But the right read here is not a classic bearish one: short interest in absolute terms is still low, while the high SIR mostly reflects weak trading volume. This is more of a thin-liquidity signal than a true short-attack signal.

Conclusions

Hachshara Hitachdashut ended 2025 in a better place than where it began the year, but not in a cleaner one. Three projects entered execution around year-end and early 2026, Menora has already put real money to work, and the pipeline is clearly more mature. At the same time, the consolidated report is still thin, cash has been consumed, and a non-trivial part of the equity layer has already migrated to minorities and partners. So the core question today is no longer whether the company has projects. The real question is how quickly those projects move from planning promise into value that is actually accessible to common shareholders.

Current thesis in one line: Hachshara Hitachdashut moved in 2025 from a planning story into an execution story, but the common-shareholder test will still be decided through cash, partner structures, and sales quality.

What changed versus the prior understanding of the company: The center of gravity shifted. Until now the main question was whether the company could secure plans and signatures. Now the question is whether it can fund, build, and still retain enough of the value it creates.

The strongest counter-thesis: The market may be right to look beyond the 2025 report because Menora has already solved much of the equity bottleneck, three projects are now in execution, and the company holds a very large expected gross-profit reservoir relative to attributable equity. On that view, the accounts are simply lagging reality.

What could change the market read in the short to medium term: Faster progress at Kiryat Yam, a full permit and financing at HaAliya HaShniya, and a visibly lower cash-burn rate in 2026 filings would improve the read. Another near-term capital raise, delays in permits, or continued soft sales terms without better cash conversion would weaken it.

Why this matters: In urban renewal, value gets created long before it becomes accessible to common shareholders. Investors who do not separate those two stages can misread the company badly in either direction.

What must happen over the next 2 to 4 quarters for the thesis to strengthen: Kiryat Yam has to enter execution, HaAliya HaShniya has to complete its permit and financing gates, the February 2026 raise has to be enough without another quick round, and the next filings have to show better conversion of construction starts into revenue and cash. Failure at any of those checkpoints would remind the market that the story is still fragile.